Allurion Technologies (ALURD) Return on Capital Employed (2023 - 2026)
Allurion Technologies' (ALURD) quarterly Return on Capital Employed came in at 118.75% in Q1 2026, up 35248.0% YoY from N/an in Q1 2025, and down 15.28% on a QoQ basis from 140.17% in Q4 2025.
Allurion Technologies (ALURD) Return on Capital Employed (2023 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 4 years of Return on Capital Employed data on file, last reported at 118.75% in Q1 2026.
- Quarterly Return on Capital Employed rose 35248.0% year-over-year to 118.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 118.75% (up 35248.0% YoY) and the FY2025 annual result came in at 213.09%, up 36338.0% from the prior year.
- Return on Capital Employed declined to 118.75% in Q1 2026, from 140.17% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 20640.43% in Q1 2024 to a low of 355.26% in Q3 2025.
- A 4-year average of 2458.32% and a median of 201.56% in 2025 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 35942 bps in 2025, down 2087416 bps in 2025.
- Tracing ALURD's Return on Capital Employed over 4 years: stood at 256.98% in 2023, then increased by 15 bps to 219.25% in 2024, then soared by 164 bps to 140.17% in 2025, then dropped by 15 bps to 118.75% in 2026.
- The last three Return on Capital Employed figures came in at 118.75% (Q1 2026), 140.17% (Q4 2025), and 355.26% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 118.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.75% |
| Dec 31, 2025 | 140.17% |
| Sep 30, 2025 | -355.26% |
| Jun 30, 2025 | -201.56% |
| Mar 31, 2025 | -233.73% |
| Dec 31, 2024 | -219.25% |
| Sep 30, 2024 | -200.18% |
| Jun 30, 2024 | -244.45% |
| Mar 31, 2024 | 20,640.43% |
| Dec 31, 2023 | -256.98% |
| Sep 30, 2023 | 7,853.56% |